Trials / Unknown
UnknownNCT00926068
Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- Sponsor
- HealOr · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, double blind, randomized, placebo controlled, outpatient, parallel group comparison trial to assess the safety and efficacy of HO/03/03 10µg versus Placebo, applied topically once daily for up to 14 weeks in at least 196 subjects diagnosed with Diabetes Mellitus and having a single target non-healing Plantar Neuropathic Diabetic Foot Ulcer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HO/03/03 10µg | |
| DRUG | Placebo |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-08-01
- First posted
- 2009-06-23
- Last updated
- 2013-04-04
Locations
33 sites across 2 countries: United States, India
Source: ClinicalTrials.gov record NCT00926068. Inclusion in this directory is not an endorsement.